MORGENTHALER VENTURE PARTNERS IX LP

CIK 00014391015 companiesMENLO PARK, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001439101

Recent Transactions

29 trades

Other
Doximity, Inc.$DOCS
Class A Common Stock
2021-11-12−8,535,175→ 8,535,175 total
Conversion
Doximity, Inc.$DOCS
Class A Common Stock
2021-11-10+17,070,350→ 17,070,350 total
Conversion
Doximity, Inc.$DOCS
Class B Common Stock
2021-11-10−17,070,350→ 0 total
Conversion
Doximity, Inc.$DOCS
Class B Common Stock
2021-06-28+17,070,350→ 17,070,350 total
Conversion
Doximity, Inc.$DOCS
Series C Preferred Stock
2021-06-28−1,659,476→ 0 total
Conversion
Doximity, Inc.$DOCS
Series B Preferred Stock
2021-06-28−15,410,874→ 0 total
Conversion
VAPOTHERM INC
Series A Convertible Preferred Stock
2018-11-16−214,285→ 0 total
Conversion
VAPOTHERM INC
Series D Convertible Preferred Stock
2018-11-16−129,418→ 0 total
Conversion
VAPOTHERM INC
Common Stock
2018-11-16+921,348→ 921,348 total
Conversion
VAPOTHERM INC
Common Stock
2018-11-16+61,342→ 982,690 total
Conversion
VAPOTHERM INC
Series C Convertible Preferred Stock
2018-11-16−359,842→ 0 total
Conversion
VAPOTHERM INC
Series B Convertible Preferred Stock
2018-11-16−217,803→ 0 total
Conversion
VAPOTHERM INC
Series D-1 Convertible Preferred Stock
2018-11-16−61,342→ 0 total
Conversion
Ra Pharmaceuticals, Inc.
Common Stock
2016-10-31+486,919→ 2,482,308 total
Exercise of In-Money
Ra Pharmaceuticals, Inc.
Common Stock
2016-10-31$0.07/sh+63,019→ 80,161 total
Exercise of In-Money
Ra Pharmaceuticals, Inc.
Warrants to Purchase Common Stock
2016-10-31−63,019→ 0 total
Conversion
Ra Pharmaceuticals, Inc.
Series B-2 Preferred Stock
2016-10-31−3,408,439→ 0 total
Conversion
Ra Pharmaceuticals, Inc.
Common Stock
2016-10-31+523,438→ 1,995,389 total
Conversion
Ra Pharmaceuticals, Inc.
Series A Preferred Stock
2016-10-31−9,744,916→ 0 total
Sale
Ra Pharmaceuticals, Inc.
Common Stock
2016-10-31$13.00/sh−340→ 79,821 total
Conversion
Ra Pharmaceuticals, Inc.
Common Stock
2016-10-31+1,392,130→ 1,471,951 total
Purchase
Ra Pharmaceuticals, Inc.
Common Stock
2016-10-31$13.00/sh+263,538→ 2,745,846 total
Conversion
Ra Pharmaceuticals, Inc.
Series B-1 Preferred Stock
2016-10-31−3,664,071→ 0 total
Purchase
Calithera Biosciences, Inc.
COMMON STOCK
2014-10-07$10.00/sh+350,000→ 2,161,915 total
Conversion
Calithera Biosciences, Inc.
SERIES B PREFERRED STOCK
2014-10-07+419,181→ 0 total
Conversion
Calithera Biosciences, Inc.
SERIES A PREFERRED STOCK
2014-10-07+10,999→ 0 total
Conversion
Calithera Biosciences, Inc.
COMMON STOCK
2014-10-07$10.00/sh+1,811,915→ 1,811,915 total
Conversion
Calithera Biosciences, Inc.
SERIES C PREFERRED STOCK
2014-10-07+747,540→ 0 total
Conversion
Calithera Biosciences, Inc.
SERIES D PREFERRED STOCK
2014-10-07+634,195→ 0 total

Companies

Recent Filings

Address

2710 SAND HILL ROAD, SUITE 100

MENLO PARK, CA, 94025

View on SEC.gov